Unleash the Power of a Small Plant

Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker, financial journalist, and money manager.

I am a passionate devotee of freedom in all its forms.

That’s why I am encouraged to see the recent shift in American public opinion favoring the legalization of cannabis/marijuana. To date, marijuana is legal for adults in 11 states and the District of Columbia, while medical marijuana is legal in 34.

With President-elect Joe Biden announcing that he favors the decriminalization of cannabis on the federal level, the path has opened for pot stocks to rise again. Those stocks generally had been in a slump since 2019 due to overproduction and a lack of profitable cannabis companies.

Thus, it is time to turn our attention to an exchange-traded fund (ETF) that has appeared in one of my trading services. The ETFMG Alternative Harvest ETF (NYSEARCA:MJ) tracks a market-cap-weighted index of global firms engaged in the legal cultivation, production, marketing or distribution of cannabis, cannabinoids or tobacco products.

Some of this fund’s top holdings include Aphria Inc. (NASDAQ: APHA), GW Pharmaceuticals PLC Sponsored ADR (NASDAQ: GWPH), Canopy Growth Corporation (NASDAQ: CGC), Aurora Cannabis Inc. (NYSE:ACB), Cronos Group Inc. (NASDAQ:CRON), GrowGeneration Corp. (NASDAQ:GRWG), Tilray, Inc. (NASDAQ:TLRY) and HEXO Corp. (NYSE: HEXO).

This fund’s performance has been relatively strong, even when including the damage done by the COVID-19 pandemic. As of Dec. 15, MJ has jumped 17.08% in the past month and 34.71% for the past three months. However, it currently is down 6.40% year to date to show how much it had fallen before its recent rebound.

Chart courtesy of www.stockcharts.com

The fund has amassed $986.33 million in assets under management and has an expense ratio of 0.75%.

While MJ does provide an investor with a chance to tap into the world of cannabis, this kind of ETF may not be appropriate for all portfolios. Thus, interested investors always should conduct their due diligence and decide whether the fund is suitable for their investing goals.

Finally, whether by reading this e-letter, subscribing to my trading services or meeting me in person, you likely know that I am a staunch advocate of freedom and I respect the personal views of others about whether to use or invest in cannabis. I further think that any legal substance that consenting adults choose to use is entirely their prerogative.

As always, I am happy to answer any of your questions about ETFs, so do not hesitate to send me an email. You just may see your question answered in a future ETF Talk.

Like This Article?
Now Get Jim's FREE Special Report:
The Top 11 Dividend ETFs to
Buy Right Now

Get up to 5X the yields of traditional income plays.

Get Access to the Report, 100% FREE


img
previous article

About this time of year, you see a whole lot of articles in the financial press touting or predicting what the best investments will be in the year to come. Sometimes, those picks turn out to be brilliantly on point. Very often, however, many a new-year prognostication falls short of expectations. This should come as no surprise, as those of us who are tasked with breaking out the crystal ball and predicting what human behavior will be like months down the road face a perilous pursuit. Take t

PREMIUM SERVICES FOR INVESTORS

Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details

LEARN MORE HERE

Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details

LEARN MORE HERE

Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details

LEARN MORE HERE

Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details

LEARN MORE HERE

Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Product Details

LEARN MORE HERE

Jon Johnson

Jon Johnson's philosophy in investing and trading is to take what the market gives you regardless if that is to the upside or downside. For the past 21 years, Jon has helped thousands of clients gain success in the financial markets through his newsletters and education services:

Product Details

LEARN MORE HERE

DividendInvestor.com

Used by financial advisors and individual investors all over the world, DividendInvestor.com is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.

LEARN MORE HERE